Compare CAKE & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAKE | INDV |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.7B |
| IPO Year | 1996 | 2014 |
| Metric | CAKE | INDV |
|---|---|---|
| Price | $104.36 | $36.06 |
| Analyst Decision | Hold | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $60.31 | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 04-29-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | ★ 2.43 | 1.67 |
| Revenue | ★ $3,751,806,000.00 | $1,239,000,000.00 |
| Revenue This Year | $6.14 | N/A |
| Revenue Next Year | $6.65 | N/A |
| P/E Ratio | $42.98 | ★ $21.47 |
| Revenue Growth | ★ 4.75 | 4.29 |
| 52 Week Low | $43.07 | $22.56 |
| 52 Week High | $118.46 | $42.81 |
| Indicator | CAKE | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 52.03 |
| Support Level | $102.42 | $35.49 |
| Resistance Level | $117.12 | $36.62 |
| Average True Range (ATR) | 3.50 | 0.89 |
| MACD | 0.01 | 0.32 |
| Stochastic Oscillator | 65.42 | 74.68 |
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).